ARS Pharmaceuticals
SPRY
SPRY
64 hedge funds and large institutions have $73.3M invested in ARS Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 14 increasing their positions, 23 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
28% less call options, than puts
Call options by funds: $2.92M | Put options by funds: $4.07M
39% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 23
Holders
64
Holding in Top 10
1
Calls
$2.92M
Puts
$4.07M
Top Buyers
| 1 | +$6.54M | |
| 2 | +$4.18M | |
| 3 | +$2M | |
| 4 |
Millennium Management
New York
|
+$1.93M |
| 5 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
+$1.35M |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$3.81M | |
| 3 | -$1.22M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.17M |
| 5 |
Two Sigma Investments
New York
|
-$880K |